Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Orbit Co-Invest A-1 appears to be a Delaware limited liability company used as an investment holding or co-investment vehicle rather than an operating life sciences, biotech, pharma, or healthcare company. Public SEC materials identify Orbit Co-Invest A-1 LLC as a reporting entity associated with share ownership in Osmotica Pharmaceuticals plc/RVL Pharmaceuticals-related securities, with Altchem Limited serving as its manager. There is no evidence from the available public record that the entity conducts drug discovery, development, manufacturing, clinical trials, or commercial healthcare operations. Accordingly, it is best characterized as a private investment SPV tied to healthcare-sector securities ownership, not as a healthcare operating company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Orbit Co-Invest A-1.